NCT00640289View on ClinicalTrials.gov

Clinical Trial of Factor XIII (FXIII) Concentrate

NACompletedINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

HemophiliaFactor XIII Deficiency

Interventions

DRUG

Fibrogammin P

Prophylaxis treatment

Trial Locations (1)

92868

Children's Hospital of Orange Co., Orange

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

CSL Behring

INDUSTRY

lead

Children's Hospital of Orange County

OTHER

NCT00640289 - Clinical Trial of Factor XIII (FXIII) Concentrate | Biotech Hunter | Biotech Hunter